Invention Grant
- Patent Title: Transdermal pharmaceutical composition
- Patent Title (中): 透皮药物组合物
-
Application No.: US10575145Application Date: 2004-10-06
-
Publication No.: US07728042B2Publication Date: 2010-06-01
- Inventor: Istvan Eros , Ildiko Pannonhalmine Csoka , Erzsebet Soosne Csanyi , Attila Bodis , Erzsebet Lapis , Erzsebet Francsicsne Czinege , Emoke Kissne Csikos , Janos Illes
- Applicant: Istvan Eros , Ildiko Pannonhalmine Csoka , Erzsebet Soosne Csanyi , Attila Bodis , Erzsebet Lapis , Erzsebet Francsicsne Czinege , Emoke Kissne Csikos , Janos Illes
- Applicant Address: HU Budapest
- Assignee: Richter Gedeon Vegyeszeti Gyar RT
- Current Assignee: Richter Gedeon Vegyeszeti Gyar RT
- Current Assignee Address: HU Budapest
- Agent Jonathan Myers; Andrew Wilford
- Priority: HU0303313 20031009
- International Application: PCT/HU2004/000092 WO 20041006
- International Announcement: WO2005/032514 WO 20050414
- Main IPC: A61K31/12
- IPC: A61K31/12
Abstract:
The invention relates to a liquid crystal gel containing polyoxyethylene-glyceryl-trioleate, propylene-glycol, isopropyl myristate and a hyaluronic acid salt or complex for use in the manufacture of transdermal pharmaceutical compositions and healing cosmetics. The invention also relates to transdermal pharmaceutical composition consists of an estrogen and a progestin component as well as a liquid crystal gel containing polyoxyethylene-glyceryl-trioleate, propylene-glycol, isopropyl myristate and a hyaluronic acid salt or complex. The invention can be applied for transdermal hormone replacement therapy and for other transdermal depending on the active principles included.
Public/Granted literature
- US20070264345A1 Transdermal Pharmaceutical Composition Public/Granted day:2007-11-15
Information query
